Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C1633
http://purl.obolibrary.org/obo/NCIT_C1633
|
|---|---|
| Preferred Name | Polyvalent Melanoma Vaccine |
| Definitions |
A cancer vaccine consisting of whole irradiated heterologous melanoma cells which express multiple melanoma-related antigens. Polyvalent melanoma vaccine may stimulate an antitumoral cytotoxic T-cell immune response in the host, resulting in inhibition of tumor cell proliferation and tumor cell death. (NCI04)
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A cancer vaccine consisting of whole irradiated heterologous melanoma cells which express multiple melanoma-related antigens. Polyvalent melanoma vaccine may stimulate an antitumoral cytotoxic T-cell immune response in the host, resulting in inhibition of tumor cell proliferation and tumor cell death. (NCI04) |
|---|---|
| prefLabel | Polyvalent Melanoma Vaccine
|
| label | Polyvalent Melanoma Vaccine
|
| PDQ_Closed_Trial_Search_ID | 43301
|
| code | C1633
|
| prefixIRI | NCIT:C1633
|
| in_subset |
See more
See less
|
| Display_Name | Polyvalent Melanoma Vaccine
|
| Preferred_Name | Polyvalent Melanoma Vaccine
|
| Contributing_Source | CTRP
|
| Maps_To | Polyvalent Melanoma Vaccine
|
| NCI_Drug_Dictionary_ID | 43301
|
| Legacy Concept Name | Polyvalent_Melanoma_Vaccine
|
| type | |
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 43301
|
| Semantic_Type |
Pharmacologic Substance
Immunologic Factor
|
| UMLS_CUI | C0299555
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |